Click the image for a Prosigna Sample Claim Form-CMS 1500
Prosigna Annotated Patient Report
Click here to download the Prosigna Annotated Patient Report.
Prosigna Patient Support Program Enrollment Form
Click here to download the Prosigna Patient Support Program Enrollment Form.
Prosigna is indicated for use in postmenopausal women with hormone receptor-positive, node-negative (Stage I or II), or node-positive (Stage II) breast cancer to be treated with adjuvant endocrine therapy.